The forecast data reveals a decreasing trend in the import of insulin into India from 2024 to 2028. Starting at 421.36 kilograms in 2024, there is a consistent yearly decrease, reaching as low as 123.46 kilograms in 2028. The year-on-year variations indicate a sharp decline, with notable reductions in the volume over the years, and a Compound Annual Growth Rate (CAGR) depicting a sustained downward trajectory over this period.
Future trends to watch for include:
- Increased domestic insulin production capabilities which could further reduce the dependency on imports.
- The potential impact of new healthcare policies or international trade agreements affecting the pharmaceutical sector.
- Technological advancements or new competitors entering the insulin production market may modify demand and supply dynamics.
